Loring Wolcott & Coolidge Fiduciary Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $984K | Buy |
|
|||||
|
2025
Q2 | $132K | Hold |
|
|||||
|
2025
Q1 | $122K | Hold |
|
|||||
|
2024
Q4 | $126K | Sell |
|
|||||
|
2024
Q3 | $115K | Buy |
|
|||||
|
2024
Q2 | $96.3K | Hold |
|
|||||
|
2024
Q1 | $83.9K | Hold |
|
|||||
|
2023
Q4 | $78K | Sell |
|
|||||
|
2023
Q3 | $68.5K | Hold |
|
|||||
|
2023
Q2 | $70.5K | Buy |
|
|||||
|
2023
Q1 | $61.7K | Hold |
|
|||||
|
2022
Q4 | $57.1K | Hold |
|
|||||
|
2022
Q3 | $48K | Hold |
|
|||||
|
2022
Q2 | $46K | Hold |
|
|||||
|
2022
Q1 | $55K | Hold |
|
|||||
|
2021
Q4 | $52K | Hold |
|
|||||
|
2021
Q3 | $54K | Sell |
|
|||||
|
2021
Q2 | $56K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $44K | Hold |
|
|||||
|
2020
Q3 | $47K | Sell |
|
|||||
|
2020
Q2 | $285K | Sell |
|
|||||
|
2020
Q1 | $331K | Buy |
|
|||||
|
2019
Q4 | $457K | Hold |
|
|||||
|
2019
Q3 | $411K | Hold |
|
|||||
|
2019
Q2 | $434K | Hold |
|
|||||
|
2019
Q1 | $388K | Hold |
|
|||||
|
2018
Q4 | $357K | Hold |
|
|||||
|
2018
Q3 | $389K | Hold |
|
|||||
|
2018
Q2 | $330K | Hold |
|
|||||
|
2018
Q1 | $276K | Hold |
|
|||||
|
2017
Q4 | $250K | Sell |
|
|||||
|
2017
Q3 | $359K | Hold |
|
|||||
|
2017
Q2 | $328K | Hold |
|
|||||
|
2017
Q1 | $306K | Hold |
|
|||||
|
2016
Q4 | $266K | Hold |
|
|||||
|
2016
Q3 | $293K | Hold |
|
|||||
|
2016
Q2 | $288K | Hold |
|
|||||
|
2016
Q1 | $232K | Hold |
|
|||||
|
2015
Q4 | $227K | Sell |
|
|||||
|
2015
Q3 | $238K | Hold |
|
|||||
|
2015
Q2 | $238K | Hold |
|
|||||
|
2015
Q1 | $238K | Hold |
|
|||||
|
2014
Q4 | $178K | Buy |
|
|||||
|
2014
Q3 | $149K | Hold |
|
|||||
|
2014
Q2 | $162K | Buy |
|
|||||
|
2014
Q1 | $161K | Hold |
|
|||||
|
2013
Q4 | $143K | Hold |
|
|||||
|
2013
Q3 | $140K | Hold |
|
|||||
|
2013
Q2 | $110K | Buy |
|